Cite
HARVARD Citation
Bousquet, J. et al. (2015). Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps. Expert opinion on pharmacotherapy. pp. 913-928. [Online].